PAPPALARDO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 9.042
EU - Europa 5.062
AS - Asia 4.629
SA - Sud America 981
AF - Africa 749
Continente sconosciuto - Info sul continente non disponibili 392
OC - Oceania 51
AN - Antartide 1
Totale 20.907
Nazione #
US - Stati Uniti d'America 8.686
SG - Singapore 2.220
RU - Federazione Russa 1.484
IT - Italia 1.316
CN - Cina 1.299
BR - Brasile 787
IE - Irlanda 599
CI - Costa d'Avorio 437
VN - Vietnam 400
UA - Ucraina 395
FR - Francia 277
CA - Canada 262
DE - Germania 223
KR - Corea 198
FI - Finlandia 147
GB - Regno Unito 124
BD - Bangladesh 109
SE - Svezia 109
NG - Nigeria 105
NL - Olanda 71
IN - India 70
BE - Belgio 63
AR - Argentina 60
AT - Austria 60
SN - Senegal 58
TR - Turchia 50
KE - Kenya 44
MX - Messico 38
AU - Australia 37
PL - Polonia 36
ZA - Sudafrica 35
HK - Hong Kong 33
IQ - Iraq 32
EC - Ecuador 30
ES - Italia 29
CO - Colombia 28
JP - Giappone 28
PK - Pakistan 28
VE - Venezuela 27
CZ - Repubblica Ceca 24
ID - Indonesia 23
UZ - Uzbekistan 20
CH - Svizzera 19
PY - Paraguay 17
BJ - Benin 16
GR - Grecia 16
IR - Iran 15
JM - Giamaica 15
NZ - Nuova Zelanda 14
CL - Cile 12
LT - Lituania 12
AE - Emirati Arabi Uniti 11
MA - Marocco 11
PT - Portogallo 11
TN - Tunisia 11
EG - Egitto 10
CR - Costa Rica 9
JO - Giordania 9
LB - Libano 9
NP - Nepal 9
UY - Uruguay 9
BG - Bulgaria 8
DZ - Algeria 8
EU - Europa 8
PE - Perù 8
SA - Arabia Saudita 7
TW - Taiwan 7
AZ - Azerbaigian 6
HN - Honduras 6
HU - Ungheria 6
IL - Israele 6
KG - Kirghizistan 6
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
PH - Filippine 5
RO - Romania 5
SV - El Salvador 5
ET - Etiopia 4
OM - Oman 4
SI - Slovenia 4
TH - Thailandia 4
AL - Albania 3
AO - Angola 3
BB - Barbados 3
GA - Gabon 3
HR - Croazia 3
LV - Lettonia 3
PA - Panama 3
PS - Palestinian Territory 3
BM - Bermuda 2
BO - Bolivia 2
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
GE - Georgia 2
KW - Kuwait 2
LU - Lussemburgo 2
MU - Mauritius 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
Totale 20.499
Città #
Dallas 1.398
Singapore 1.273
Santa Clara 1.122
Chandler 752
Moscow 617
San Jose 610
Dublin 582
Abidjan 437
Jacksonville 408
Ashburn 397
Chicago 329
Houston 304
Catania 272
Council Bluffs 259
Boardman 248
Hefei 231
Beijing 199
Seoul 190
Staranzano 187
Lauterbourg 167
Los Angeles 167
Cambridge 163
Lawrence 159
Andover 152
Nanjing 140
Ho Chi Minh City 130
Toronto 129
Des Moines 96
Hanoi 96
Helsinki 96
Civitanova Marche 86
Nuremberg 86
Rome 70
São Paulo 66
New York 64
Brussels 59
Dakar 58
San Mateo 58
Nanchang 56
Buffalo 52
Wilmington 51
Abuja 47
Lappeenranta 45
Bremen 43
Lagos 43
The Dalles 39
Columbus 36
Hebei 36
Ottawa 35
Shenyang 35
Montreal 34
Vienna 33
Saint Petersburg 31
Hong Kong 30
Jiaxing 29
Dong Ket 28
Milan 28
Tianjin 28
Warsaw 28
Palermo 27
Amsterdam 26
Munich 25
Phoenix 24
Seattle 24
Belo Horizonte 23
Rio de Janeiro 23
Denver 22
Naples 22
Atlanta 21
Nairobi 21
Tokyo 21
Changsha 20
Haiphong 20
Orem 20
Boston 19
Brno 19
Brooklyn 19
Falls Church 19
Johannesburg 19
Messina 19
Pozzallo 19
Shanghai 19
Kayseri 18
Turin 18
Chennai 17
Poplar 17
San Giovanni la Punta 17
Cotonou 16
London 16
Stockholm 16
Da Nang 15
Norwalk 15
Port Harcourt 15
Salvador 15
Zhengzhou 15
Acireale 14
Charlotte 14
Melbourne 14
Porto Alegre 14
San Francisco 14
Totale 13.415
Nome #
((2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 326
Parallel Pair-Wise Interaction for Multi-Agent Immune Systems Modelling 230
A Credibility Assessment Plan for an In Silico Model that Predicts the Dose-Response Relationship of New Tuberculosis Treatments 201
2DIs: a SBML compliant web platform for the design and modeling of immune system interactions 200
A MapReduce Based Tool for the Analysis and Discovery of Novel Therapeutic Targets 195
Agent based modeling of relapsing multiple sclerosis: A possible approach to predict treatment outcome 184
Computational modelling in melanoma for novel drug discovery 183
A methodological approach for using High-Level Petri Nets to model the immune system response 182
A biological optimization problem on the Grid 181
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis 177
Agent based modeling of the immune system: NetLogo, a promising framework 174
Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer 173
Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis 170
R- ed S-LP2: sintesi, molecular docking e valutazione farmacologica 167
A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets 166
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 165
A computational model to predict the immune system activation by citrus derived vaccine adjuvants 163
A MapReduce tool for in-depth analysis of KEGG pathways: identification and visualization of therapeutic target candidates 163
An agent based modeling approach for the analysis of tuberculosis - Immune system dynamics 161
Advancing PFAS risk assessment: Integrative approaches using agent-based modelling and physiologically-based kinetic for environmental and health safety 159
Boosting multiple sclerosis lesion segmentation through attention mechanism 159
A novel paradigm for cell and molecule interaction ontology: from the CMM model to IMGT-ONTOLOGY 157
A genetic algorithm for shortest path motion problem in three dimensions 155
A modeling framework for immune-related diseases 155
Nose-to-Brain Drug Delivery and Physico-Chemical Properties of Nanosystems: Analysis and Correlation Studies of Data from Scientific Literature 154
Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid Cancer 154
The Potential of Computational Modeling to Predict Disease Course and Treatment Response in Patients with Relapsing Multiple Sclerosis 151
Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression 150
A model of cytotoxic T antitumor activation stimulated by pulsed dendritic cells 149
PEAK: A Clever Python Tool for Exploratory, Regression, and Classification Data. A Case Study for COVID-19 147
iAtheroSim: atherosclerosis process simulator on smart devices. 146
A computational approach based on the colored Petri net formalism for studying multiple sclerosis 146
Combining agent based-models and virtual screening techniques to predict the best citrus-derived vaccine adjuvants against human papilloma virus 142
In silico clinical trials: concepts and early adoptions 142
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 142
Enhancing Multiple Sclerosis Lesion Segmentation in Multimodal MRI Scans with Diffusion Models 139
Anthropometric estimates can predict satisfaction with breast in a population of asymptomatic women 136
Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza 136
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS) 135
BIOESOnet: A Tool for the Generation of Personalized Human Metabolic Pathways from 23andMe Exome Data 133
DNA methylation and gene expression in melanoma: A large-scale integrated analysis 133
Agent based simulations in disease modeling Comment on “Towards a unified approach in the modeling of fibrosis: A review with research perspectives” by Martine Ben Amar and Carlo Bianca 132
Agent based modeling of lung metastasis-immune system competition 132
Combining Parallel Genetic Algorithms and Machine Learning to Improve the Research of Optimal Vaccination Protocols 131
Analysis of vaccine's schedules using models, 130
Agent based modeling of humoral response to atherogenesis 130
Advances in Computational Immunology 129
In silico design of recombinant multi-epitope vaccine against influenza A virus 127
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 126
Moving forward through the in silico modeling of tuberculosis: a further step with UISS-TB 125
MSLesSeg: baseline and benchmarking of a new Multiple Sclerosis Lesion Segmentation dataset 124
Computational identification of differentially-expressed genes as suggested novel COVID-19 biomarkers: A bioinformatics analysis of expression profiles 124
Design and optimization of PEGylated nanoparticles intended for Berberine Chloride delivery 122
A multi-step and multi-scale bioinformatic approach to investigate potential source of cross-reactive immunity against SARS-CoV-2 UK variant 122
Agent based modeling of atherosclerosis: a concrete help in personalized treatments 121
Evaluation of the efficacy of RUTI and ID93/GLA-SE vaccines in tuberculosis treatment: in silico trial through UISS-TB simulator 118
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review) 118
Computational models to predict disease course and treatment response in multiple sclerosis 118
Model verification tools: a computational framework for verification assessment of mechanistic agent-based models 117
A hybrid model of the immune response against lung metastases 114
SimB16: modeling induced immune system response against B16-melanoma 114
Analysis of vaccine's schedules using models, 112
Reverse Vaccinology for Influenza A Virus: From Genome Sequencing to Vaccine Design 111
Modeling Cutaneous Leishmaniasis: Insights into M1/M2 Macrophage Dynamics Using the Universal Immune System Simulator 108
Modeling the competition between lung metastases and the immune system using agents 108
Credibility of In Silico Trial Technologies - A Theoretical Framing 108
GPU accelerated analysis of treg-teff cross regulation in relapsing-remitting multiple sclerosis 107
Computational modeling of the expansion of human cord blood CD133+ hematopoietic stem/progenitor cells with different cytokine combinations 107
Genetic Algorithm-Based Prediction of Emerging SARS-CoV-2 Variants: A Computational Biology Perspective 106
Cutaneous Leishmaniasis: discovering new effective therapies using the Universal Immune System Simulator 106
Current issues in tumor immunology 106
Optimization of HAART by means of Genetic Algorithms and agent based models of HIV infection 106
Cancer immunoprevention: What can we learn from in silico models? 106
Modeling and Simulation of anakinra effects on severe COVID19 Patients 105
Computational modelling and simulation for immunotoxicity prediction induced by skin sensitisers 105
Toward computational modelling on immune system function 105
PETAL: A Python tool for deep analysis of biological pathways 105
SHyFTA, a Stochastic Hybrid Fault Tree Automaton for the modelling and simulation of Dynamic Reliability problem 104
Sexual risk behaviours 103
Modeling biology spanning different scales: An open challenge 101
In silico evaluation of daclizumab and vitamin D effects in multiple sclerosis using agent based models 101
Text mining and word embedding for classification of decision making variables in breast cancer surgery 99
Induction of T cell memory by a dendritic cell vaccine: a computational model 99
Persistence analysis in a Kolmogorov-type model for cancer-immune system competition 99
GRIDUISS - A grid based universal immune system simulator framework 99
How can we accelerate COVID-19 vaccine discovery? 99
Moving forward through the in silico modeling of multiple sclerosis: Treatment layer implementation and validation 98
Combining cellular automata and lattice Boltzmann method to model multiscale avascular tumor growth coupled with nutrient diffusion and immune competition 98
Using Continuous Petri Nets to predict the impact of microRNA analysis in PI3K/Akt and MAPK Signaling Pathways 98
Introducing scale factor adjustments on agent-based simulations of the immune system 98
Mathematical and computational models in tumor immunology 97
Compartmental mathematical modeling of immune system - melanoma competition 95
Generation of digital patients for the simulation of tuberculosis with UISS-TB 95
A Comparative Evaluation of Diffusion Based Networks for Multiple Sclerosis Lesion Segmentation 93
Vaccine protocols optimization: in silico experiences 93
Universal Immune System Simulator framework (UISS) 93
Modelling Vaccine Protocols 93
Uncertainty quantification and sensitivity analysis for in silico trial platform: A preliminary application on UISS-MS 93
Computational modeling of brain pathologies: the case of multiple sclerosis 92
Translational immunomics of cancer immunoprevention 92
Totale 13.198
Categoria #
all - tutte 71.816
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022881 0 0 7 19 190 11 166 49 103 21 44 271
2022/20232.112 183 120 28 251 194 364 12 342 464 18 71 65
2023/20241.514 53 382 73 49 29 230 34 113 14 209 202 126
2024/20254.183 97 602 218 224 921 511 305 145 250 376 258 276
2025/20268.861 499 509 1.644 575 1.240 1.786 845 200 470 505 315 273
2026/2027961 291 402 268 0 0 0 0 0 0 0 0 0
Totale 20.907